Levophacetoperane

Levophacetoperane
Systematic (IUPAC) name
[(R)-phenyl-[(2R)-piperidin-2-yl]methyl] acetate
Clinical data
Legal status
  • (Prescription only)
Routes of
administration
Oral
Identifiers
CAS Number 24558-01-8 YesY
ATC code None
PubChem CID 65715
Chemical data
Formula C14H19NO2
Molar mass 233.31 g/mol
  (verify)

Levophacetoperane (Lidépran,Phacétoperane) is a psychostimulant developed by Rhône-Poulenc in the 1950s.[1] The drug has been used as an antidepressant and anorectic.[2][3] It is the reverse ester of methylphenidate. The reverse esters of many drugs which contain an ester group in their structure such as pethidine and cocaine show similar activity to the parent compound.[4]

See also

References

  1. US Patent 2928835 - New Esters
  2. Delbeke FT, Debackere M. Isolation and detection of methylphenidate, phacetoperane and some other sympatomimetic central nervous stimulants with special reference to doping. I. Gas chromatographic detection procedure with electron capture detection for some secondary amines. Journal of Chromatography. 1975 Mar 26;106(2):412-7.
  3. O'Neil, Maryadele J. (2001). The Merck index: an encyclopedia of chemicals, drugs, and biologicals. Rahway, NJ: Merck Research Laboratories. ISBN 0-911910-13-1.
  4. Janssen PAJ, Eddy NB. Compounds Related to Pethidine - IV. New General Chemical Methods of Increasing the Analgesic Activity of Pethidine. Journal of Medicinal and Pharmaceutical Chemistry. 1960; 2(1): 31-45.


This article is issued from Wikipedia - version of the Tuesday, September 10, 2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.